FDA widens the Tylenol probe

May 18th, 2010 - 8:05 pm ICT by Aishwarya Bhatt  

Washington DC, May 18 (THAINDIAN NEWS) The Food and Drugs Administration has widened its Tylenol probe to include all the McNeil’s manufacturing plants. The FDA announced this on Monday. McNeil is a subsidiary of Johnson & Johnson and it manufactures the infant versions of the generic drug Tylenol. Officials announced after inspection of the company’s manufacturing plant in Fort Washington, Pa. on the 6th of May, that the company does not follow good manufacturing procedures.

The report also said there was bacterial contamination of the drugs. The FDA has therefore decided to include all the manufacturing plants of the company, to verify if the company is having similar problems companywide. The FDA also announced that the move will help them to know exactly how they can help the company solve the problem.

McNeil has announced that it has shut down its plant in Fort Washington and it is conducting a comprehensive quality assessment. The statement said the plant would remain shut down, until the company finds a way to solve the quality control challenges that it is facing. The statement also said the company is cooperating fully with the Food and Drugs Administration to find a solution to the problem.

It may be recalled that on the 1st of May, McNeil recalled about 50 versions of pediatric generic drugs that included Tylenol, Motrin and Benadryl.

Related Stories

Tags: , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe